NYSE · Medical - Diagnostics & Research

RVTY (RVTY) Stock

$115.02 +3.26% NYSE: RVTY Healthcare

Valuation

MetricValue
Price$115.02
Market Cap$12.83B
P/E Ratio46.33
P/B Ratio1.48
P/S Ratio3.68
EPS (TTM)$2.08
52-Week High$118.30
52-Week Low$81.22
Dividend Yield0.29%

Financials & Margins

MetricValue
ROE3.34%
ROA1.99%
ROCE4.92%
Gross Margin12.50%
Operating Margin12.50%
Net Margin8.30%
Debt/Equity0.47
Current Ratio1.68

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.8B$3.3B$2.8B$2.8B$2.9B
Operating Profit$1.3B$781.0M$399.0M$411.0M$357.0M
Net Profit$943.0M$569.0M$-118.0M$296.0M$242.0M
EPS$8.08$4.50$-0.95$2.41$2.08
Op Margin35.0%23.6%14.5%14.9%12.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$15.0B$14.1B$13.6B$12.4B$12.2B
Total Liabilities$7.9B$6.7B$5.7B$4.7B$4.9B
Cash$603.0M$454.0M$913.0M$1.2B$920.0M
Borrowings$5.2B$4.6B$4.1B$3.3B$3.5B

Latest News

Revvity to Launch Signals for Startups for Emerging Biotech Companies Zacks · Jul 22, 2026 Revvity Launches "Signals for Startups" to Help Emerging Biotechs Build Scalable Digital Foundations from Day One Business Wire · Jul 20, 2026 Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure Business Wire · Jul 20, 2026 TD Cowen Adjusts Price Target on Revvity to $130 From $120, Maintains Buy Rating MT Newswires · Jul 15, 2026 Alamar Hits A High Note On Alzheimer's Buzz Trefis · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.4B$680.0M$91.0M$628.0M$582.0M
Investing Cash Flow$-4.2B$-218.0M$1.2B$690.0M$-91.0M
Financing Cash Flow$-94.0M$-81.0M$-395.0M$-371.0M$-825.0M
Net Cash Flow$217.0M$-149.0M$444.0M$250.0M$-245.0M
Free Cash Flow$1.3B$594.0M$10.0M$542.0M$508.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA20.25
FCF Yield4.62%
Quick Ratio1.41
Interest Coverage3.88
Return 1Y22.16%
Return 3Y-14.86%
Return 5Y-30.12%

Ownership

Insiders Held0.35%
Institutions Held106.37%
Institutions Float Held106.75%
Institutional HolderSharesReport Date
T. Rowe Price Investment Management, Inc.22,198,4222026-03-31
Price (T.Rowe) Associates Inc10,090,1582026-03-31
Edgepoint Investment Group Inc.8,800,8632026-03-31
Janus Henderson Group PLC8,348,1272026-03-31
Vanguard Capital Management LLC7,329,9802026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALGNAlign Technology, Inc. $169.29 +1.36% 27.86 $12.12B 0.00%
CRL $232.51 -0.90% -54.59 $11.20B 0.00%
ENSG $181.35 +1.84% 25.83 $10.60B 0.16%
EXASExact Sciences Corporation $104.91 -95.37 $20.03B 0.00%
GHGuardant Health, Inc. $145.13 -1.49% -43.46 $19.24B 0.00%

About RVTY

RVTY is led by CEO Prahlad R. Singh, employs 11,000 people, headquartered in Waltham, US, publicly traded since 1965.

RVTY stock trades at $115.02 with a market capitalization of $12.83B. The stock is valued at a price-to-earnings (P/E) ratio of 46.33, price-to-book of 1.48, price-to-sales of 3.68. Over the past 52 weeks the stock has ranged between $81.22 and $118.30, and currently trades 2.8% below its 52-week high. It pays a dividend yielding 0.29%.

On profitability, RVTY generates a return on equity (ROE) of 3.34%, return on capital employed of 4.92%, an operating margin of 12.50%, a net profit margin of 8.30%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides